Prognostic impact of protein kinase C β II expression in R-CHOP-treated diffuse large B-cell lymphoma patients - Riihijärvi, Sari; Koivula, Satu; Nyman, Heidi; Rydström, Karin; Jerkeman, Mats; Leppä, Sirpa (Modern pathology, 2010)
Keywords: 692/53/2422; 692/699/67/1059; 692/699/67/1990/291/1621/1915; Aged; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Cancer and Oncology; Cancer och onkologi; Chi-Square Distribution; Clinical Medicine; Cyclophosphamide - therapeutic use; Doxorubicin - therapeutic use; Female; Humans; Immunohistochemistry; Klinisk medicin; Laboratory Medicine; Lymphoma, Large B-Cell, Diffuse - drug therapy; Lymphoma, Large B-Cell, Diffuse - metabolism; Lymphoma, Large B-Cell, Diffuse - mortality; Male; Medical and Health Sciences; Medicin och hälsovetenskap; Medicine; Medicine & Public Health; Middle Aged; original-article; Pathology; Prednisone - therapeutic use; Prognosis; Proportional Hazards Models; Protein Kinase C - metabolism; Protein Kinase C beta; Retrospective Studies; Tissue Array Analysis; Vincristine - therapeutic use; II; diffuse large B-cell lymphoma; prognosis; R-CHOP; protein kinase C